Introduction
changes at different UDP-GlcNAc concentrations (38) . Both in vitro and in vivo data support a model where increased UDP-GlcNAc levels, due to hyperglycemia, result in increased O-GlcNAc levels, leading to insulin resistance, a hallmark of type II diabetes (1, 39) . These data and others have led researchers to propose that O-GlcNAc is a nutritional sensor (1, [39] [40] [41] .
In response to multiple forms of stress, cells rapidly increase glucose uptake. The ability of cells to transport glucose has been linked to the capacity of cells to respond and survive deleterious cellular conditions (42) (43) (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) . In many studies, blocking both glycolysis (48, 51, 57) and the hexosamine biosynthetic pathway (58) (59) (60) (61) results in decreased survival of cells. In some instances, alternative energy sources have been provided suggesting that depletion of ATP levels does NOT explain the decrease in survival (48, 51, 57) . Several insulin resistant models, including the long-lived Caenorhabditis elegans Daf-2 knockout, have an increased stress tolerance to a variety of agents (62) (63) (64) . Based upon these data, and recent observations suggesting that heat shock protein (HSP) 70 may act as an O-GlcNAc lectin (65), we investigated the possible link between stress tolerance and O-GlcNAc. We demonstrate that in response to all forms of cellular stress tested, multiple cell lines rapidly and dynamically increase O-GlcNAc levels on myriad nuclear and cytoplasmic proteins. Moreover, modulation of O-GlcNAc levels alters thermotolerance. Increasing O-GlcNAc levels result in cells that are more thermotolerant, while decreasing levels of O-GlcNAc protein modification led to cells that are more sensitive to thermal stress. The extent of O-GlcNAc protein modification appears to affect the levels of the heat shock proteins, HSP70 and HSP40, suggesting a molecular mechanism for these findings. This study provides a molecular link, O-GlcNAc, between glucose metabolism and stress tolerance, and suggests a new paradigm in the regulation of stress mediated signal transduction pathways.
Experimental Procedures

Cell lines and Culture Conditions
All cells (unless indicated) were from the ATCC and were maintained in DMEM (1g/L; Mediatech) supplemented with 10% (v/v) fetal bovine serum (FBS) and penicillin/streptomycin at 37 o C in a humidified incubator at 5% CO 2 . Cells were seeded 48h prior to the beginning of stress treatments as follows: Cos-7 (green monkey kidney For multiple stress experiments, cells were serum-starved 18h prior to stress treatments. Cells were treated for 8h as follows: 1mM H 2 O 2 , 50µM CoCl 2 , 4% (v/v) ethanol, 100mM NaCl (in addition to physiological saline), 75µM sodium arsenite. In other treatments, cells were thermally stressed as above or treated with UVB for 90s, and recovered at 37 o C for 8h. Treatment levels were chosen that resulted in <10% cell death and are similar to those reported by others. Experiments were performed in duplicate a minimum of 4 times. In densitometry derived from these experiments, error bars represent one standard deviation. P-values are the result of a paired student T-test (twotailed). For densitometry O-GlcNAc levels were normalized to actin to control for protein load
Analysis of Proteins
Cells were washed with ice-cold PBS, harvested and extracted with 1% (v/v) NP-40 in Tris-HCl (pH 7.4), 0.1mM PMSF, 1mM DTT, 2µM PUGNAc, 5mM KF, 0.5mM orthovanadate, 5mM β-glycerophosphate, 2mM EDTA, PIC1, PIC2. Extracts were separated by non-continuous reducing SDS-PAGE on Tris-Glycine Gels (Criterion, BIORAD, CA). Proteins transferred to nitrocellulose and blocked with 3% (w/v) BSA were detected with anti-HSP110, HSP90, HSP/HSC 70, HSP70, HSP40, and HSP27 antibodies (Stressgen, Canada), anti-O-GlcNAc antibody (CTD 110.6; Covance, PA) (67), anti-OGT (AL28) (68), anti-heat shock factor 1 (HSF1; Stressgen, Canada), antitubulin (Sigma, MO) or anti-actin (Sigma, MO).
Densitometry was performed using non-saturated chemiluminescent exposed films and quantitated using MacBAS bio-imaging analyzer (version 2.5, Fuji Photo Film Co). Typically, multiple exposures from the same experiment were used to confirm that the signal was within the linear range. Levels of O-GlcNAc in the entire lane were normalized to the appropriate control (actin or tubulin), and then expressed as a percentage of control (set at 100%). In all instances, data is averaged from independent experiments.
O-GlcNAcase and OGT Assays
Total cell extracts (40µg), either NP-40 (described above) or nuclear/cytoplasmic extracts (69), were assayed for O-GlcNAcase (EC 3.2.1.52), the enzyme which removes O-GlcNAc, activity using pNP-GlcNAc as described earlier (70, 71) . Activity is reported as nmoles of cleavage, per min, per mg of cell extract. To determine OGT activity, OGT was immunoprecipitated from NP-40 extracts (described above) of heat stressed cells as follows. NP-40 extracts (500µg), were diluted to 0.5mg/ml and 0.2%NP-40, and were pre-cleared with pre-immune antibody (100µl) covalently coupled to CNBR-activated agarose (6mg/ml) for 2h at 4 o C. Extracts were then precipitated with anti-OGT antibody (AL28; 100µl) covalently coupled to CNBR-activated agarose (6mg/ml) for 2h at 4 o C.
Resin was washed with 1ml each of Tris-HCl buffered saline pH7.4 (TBS) 0.2% (v/v) NP-40, TBS, and OGT desalting buffer (20mM Tris-HCl pH 7.8, 20% glycerol, 0.02% azide). OGT was assayed on beads against the casein kinase II (CK II) acceptor peptide as previously reported (38) . Activity is reported as µmoles of GlcNAc transferred to CK II per min per mg of cell extract immunoprecipitated from. Activity was normalized to levels of OGT in cell precipitates by densitometry.
Cre-Lox Recombination
Viral infections using adenovirus carrying either a control vector (Neo) and Crerecombinase vector (Cre) were carried out as previously reported (66) , except that 1x10 6 cells were seeded in 100mm plates. Infected cells were selected in G418 (final 1mg/ml).
Prior to stress and thermal kill experiments G418 was washed out and cells were allowed to recover for 2h.
Thermal Survival
Media was changed 1h prior to the initiation of thermal survival experiments.
Cells were stressed at indicated temperatures (45) (46) (47) (48) o C depending on cell type) in a humidified incubator (5% CO 2 ) for 0-80min and then placed at 37 o C for 24h. Cell viability was assessed using the crystal violet method (72) . To allow for differences in growth rates derived from modulating O-GlcNAc levels, viability is expressed as a percentage of unstressed cells. All experiments were performed a minimum of three times and numbers are derived from at least 4 replicates. Error bars represent one standard deviation; P-values are the result of a paired student T-test (two-tailed).
RNA Interference (RNAi)
Neuro-2A cells were seeded at 1x10 
O-GlcNAc is Added Rapidly and Dynamically in Response to Thermal Stress
In order to determine if O-GlcNAc was added to proteins in a dynamic fashion, consistent with a role in stress associated signal transduction pathways, the rate of addition of O-GlcNAc in response to hyperthermia was studied. O-GlcNAc levels were appreciably elevated at the termination of thermal stress (Fig. 3A , time post-heat stress 0 min), suggesting that O-GlcNAc addition is rapidly induced soon after the initiation of hyperthermia. This addition is dynamic, as levels of O-GlcNAc continued to increase for 9h, but are reduced by 24h and return to normal by 48h (Fig. 3B) . Notably, O-GlcNAc induction occurs prior to elevation of HSP70 protein levels (Fig. 3B) . Interestingly, OGT levels appear to become somewhat depressed post-stress (Fig. 3B) .
The rapid elevation of O-GlcNAc in response to hyperthermia was insensitive to cycloheximide (20µg/ml), the proteosome inhibitor 20µM ALLN (20µM MG132, data not shown), and the lysosomal inhibitor chloroquine (100µM) indicating that protein synthesis and degradation are not required (Fig. 3C) . The former is consistent with protein synthesis being inhibited at temperatures above 42 o C in mammalian cells.
Interestingly, inhibition of the proteasome and lysosome augmented the increase in OGlcNAc in response to stress (Fig 3C) , which may represent a decrease in the degradation of O-GlcNAc modified proteins. Levels of O-GlcNAc in control cells are elevated in chloroquine and ALLN treated cells, suggesting that increased O-GlcNAc is due to inhibition of protein degradation. Inhibition of the proteasome has been previously shown to initiate a cellular stress response (73, 74) . These data suggests that like tyrosine phosphorylation (75) , O-GlcNAc protein modification is rapidly increased after stress, and that O-GlcNAc may mediate stress induced signal transduction pathways.
Increased OGT Activity in Response to Hyperthermia.
To determine what meditates increased O-GlcNAc in response to stress, we next examined the levels and activities of the enzymes that add and remove O-GlcNAc. In response to thermal stress, no difference in O-GlcNAcase protein level was observed (Fig. 4A) . Moreover, O-GlcNAcase activity was not decreased (Fig. 4B) , suggesting that increased O-GlcNAc removal is not contributing to increased O-GlcNAc protein modification in response to stress. Levels of OGT protein are also not increased in response to thermal stress (Fig. 4C) , unlike other forms of stress (Fig. 1C) . However, OGT activity is increased in response to thermal stress (Fig. 4D) , suggesting posttranslational regulation of the enzyme.
Thermotolerance is Affected by O-GlcNAc Levels
To determine what function O-GlcNAc might play in stress response pathways, thermotolerance of cells was determined after the levels of O-GlcNAc were directly modulated using a MEF cell line in which the OGT gene is flanked by loxP sites (66) .
Infection of these cells with retrovirus carrying a vector encoding Cre recombinase leads to cells lacking the OGT gene and results in reduced OGT protein (Fig. 5A upper) and OGlcNAc (Fig. 5A middle) . Deletion of OGT has previously been shown to be lethal (76) .
Nevertheless, these cells like ES cells and OGT knockout tissues remain viable for several days during which time, protein and RNA synthesis appear unaffected (66) .
Interestingly, in control cells an increase in O-GlcNAc levels is seen in response to viral infection (Fig. 5A) , this is observed with both adenoviral and retroviral infections in other systems (data not shown) and is consistent with viral infection inducing stress response pathways (77, 78) . As shown (Fig. 5B) , when cells were challenged with an osmotic stress (100mM NaCl), Cre-infected cells were unable to increase levels of O-GlcNAc. The thermotolerance of the MEF cells that received the control retrovirus vector lacking Cre was found to be greater (at time points where there was significant cell death) (Fig. 5C ).
To control for differences in growth rate, cell viability is expressed as a percentage of unstressed cells.
To confirm these data in an independent system, OGT levels were reduced using RNAi in Neuro-2A cells (Fig. 5D) . The thermotolerance of the wild-type cells (transfected with scrambled siRNA duplex) was compared and found to be greater than those with less OGT and O-GlcNAc (Fig. 5E ). These data suggest that O-GlcNAc/OGT is necessary for cells to withstand cellular stress.
We next determined the thermotolerance of cells whose levels of O-GlcNAc were elevated by inhibiting the enzyme that removes O-GlcNAc. Cells treated with the competitive inhibitor PUGNAc (Ki=53nM) of O-GlcNAcase (79,80) had increased viability when challenged with a lethal thermal stress (Fig. 6A,B ). An increase in thermotolerance after PUGNAc treatment was also observed in Neuro-2A cells (data not shown). Notably, PUGNAc did not appear to affect HSP70 levels suggesting that the drug itself was not causing a stress (Fig 6A) . Moreover, this is consistent with the data of Haltiwanger and colleagues who showed that prolonged treatment of multiple cell lines with PUGNAc had little effect on growth rates (80).
In independent experiments, Cos-7 cells were transiently transfected with either vector (pShuttle) or vector containing OGT (pShuttle-OGT), and thermotolerance was measured. As shown (Fig. 6C,D) , cells over expressing OGT exhibited both an increase in basal O-GlcNAc levels ( Fig 6D) and in thermotolerance (Fig. 6C) . Notably, levels of O-GlcNAc are elevated prior to stress and appeared to increase faster in cells transfected with OGT (Fig. 6D) . These data indicate that cells elevate the O-GlcNAc modification of proteins as part of a pro-survival mechanism.
Modulating O-GlcNAc Levels Alters Expression of HSP70 and HSP40
To determine what role O-GlcNAc plays in protecting cells from stress, the induction of HSP70 in response to thermal stress was studied. In the presence of PUGNAc, HSP70 levels are appreciably elevated at 5h, whereas they do not reach an equivalent level in control cells until 9h (Fig. 7A upper) . In response to stress, the transcription factor HSF1 becomes hyperphosphorylated and translocates to the nucleus where it activates the transcription of HSP70. As the cell's requirement for HSP70 abates, HSP70 can bind to and deactivate HSF1 (81) . In cells treated with PUGNAc, no difference in the basal level of activated HSF1 was observed, again suggesting the cells were not stressed by treatment with PUGNAc. However, consistent with the increased rate of induction of HSP70 expression, HSF1 activation is suppressed by 9h in PUGNActreated cells, but not in control cells (Fig. 7A lower) .
We next examined the levels of two other HSPs, HSP27 and HSP40, since overexpression of these proteins have been shown to protect cells against lethal forms of stress (78) . Increased O-GlcNAc levels, a result of PUGNAc treatment prior to stress, had little effect on HSP27 levels. However, HSP40, like HSP70 was induced at a faster rate (Fig. 7B) . Interestingly, in cells where the levels of O-GlcNAc had been reduced by deletion of the OGT gene, expression of HSP40 and HSP70 were also reduced (Fig. 7C) .
Blocking the hexosamine biosynthetic pathway with DON, an inhibitor of glutamine fructose-6-amido transferase, which results in a mild reduction in O-GlcNAc lowers HSP70 levels (Fig7D). These data suggest that the protective effects of O-GlcNAc are mediated in part by the modulation of HSP40 and HSP70 levels.
Discussion
Stress, whether environmental, physiological, or chemical, induces signal transduction events that culminate in the activation/production of proteins/compounds that attenuate the effects of deleterious cellular conditions and counteract signals promoting apoptosis (and necrosis) (77, 78) . Protein phosphorylation is typically the mechanism associated with these signal transduction pathways. In this study, we have shown that mammalian cells undergo a rapid, dynamic and global increase in O-GlcNAc protein modification in response to noxious thermal, chemical, and biological stimuli;
and that this appears to modulate stress tolerance suggesting that O-GlcNAc is an additional mechanism by which cells sense and respond to stress.
Multiple forms of cellular stress induce higher levels of O-GlcNAc protein modification in diverse mammalian cell types, suggesting that increased O-GlcNAc is general response to detrimental cellular conditions. Inhibition of protein synthesis and protein degradation does not inhibit this increase suggesting that it is a dynamic posttranslational event. Moreover, in response to thermal stress OGT, the enzyme that adds O-GlcNAc, is rapidly activated (Fig. 4D) . Many cellular stresses result in a change in intracellular pH drop of as much as 0.5 pH units, from pH7.2-7.4. OGT has a pH optima close to pH 6 (82), and a pH drop alone may result in increased intracellular OGT activity. However, unless this pH change results in a covalent modification of the enzyme it is unlikely to be translated to the in vitro assay used in this study. Notably, OGT has been shown to be modified by tyrosine phosphorylation and O-GlcNAc modification (68) , although the effects of these post-translational modifications on the activity and localization of OGT remain elusive. In response to some forms of cellular stress, namely osmotic (NaCl), ethanolic (ethanol) and oxidative (sodium arsenite) stress, levels of OGT increase at the protein level. This data suggests that multiple mechanisms targeting OGT result in increased O-GlcNAc protein modification in response to stress.
In response to stress, many cell types increase glucose uptake and several studies have linked stress tolerance to elevated glucose flux (48) . Two to five percent of the glucose transported into cells is converted to UDP-GlcNAc through the hexosamine biosynthetic pathway (83) . Previously we have shown that OGT is directly regulated by the concentration of UDP-GlcNAc (38) , with its activity increasing as UDP-GlcNAc levels increase. Thus, another mechanism by which cells increase O-GlcNAc in response to stress is by increasing pools of UDP-GlcNAc, as a result of stress induced glucose uptake (48) . Notably, oxidative stress activates the hexosamine biosynthetic pathway (84) and inhibition of the hexosamine biosynthetic pathway has been shown to ablate glucosemediated protection of cells in some models (59) .
Modulation of O-GlcNAc levels alters thermotolerance in independent systems, increasing levels of O-GlcNAc increases thermotolerance (Fig. 6 ) while decreasing OGlcNAc levels sensitizes cells to stress (Fig 5) . These data suggest that O-GlcNAc plays a positive role in cellular survival, in contrast to previous studies which indicated that reducing levels of O-GlcNAc correlates with reduced sensitivity to apoptotic stimuli (85) .
Interestingly, O-GlcNAcase is rapidly cleaved by caspase-3 after apoptosis and remains active, suggesting that that removal of O-GlcNAc is part of the apoptotic cascade (71) . The mechanisms of O-GlcNAc mediated stress tolerance suggested by our findings include the faster induction of HSP70 and HSP40 (Fig. 7A, B) , overexpression of which are known to increase stress tolerance. Decreasing O-GlcNAc levels by deletion of the OGT (Fig. 5, Fig. 7C ) or by reducing O-GlcNAc levels by blocking the hexosamine biosynthetic pathway with DON (Fig. 7D) 
